Hydrocortisone Use in Pregnant Women

Safety Profile During Pregnancy

The American Academy of Allergy, Asthma, and Immunology recommends using the lowest effective dose for the shortest duration needed to control hemorrhoid symptoms in pregnant women, particularly after the first trimester 1

The European Respiratory Society recommends exercising caution during the first trimester when using topical corticosteroids due to potential risks 1
The European Respiratory Society advises avoiding prolonged continuous use of topical hydrocortisone without medical supervision 1

The American College of Rheumatology suggests that oral prednisone and prednisolone are not associated with increased major birth defects and can be used during pregnancy when needed to control active disease 2, 3
Daily doses of oral prednisone and prednisolone ≤5 mg are associated with low risk, whereas higher doses (>5 mg/day) carry dose-related risks including gestational diabetes, pregnancy-associated osteoporosis, serious maternal infections, and preterm birth 2, 3
The European Respiratory Society recommends using hydrocortisone intravenously during active labor and cesarean section in women receiving oral steroids (≥7.5 mg daily for at least 2 weeks) to prevent maternal hypothalamic-pituitary-adrenal axis suppression 4

The American Academy of Allergy, Asthma, and Immunology recommends first-line conservative measures, including increasing dietary fiber (approximately 30g/day), adequate fluid intake, stool softeners, and toilet habit training 1

Approximately 80% of pregnant women are affected by hemorrhoids, particularly in the third trimester, making this a common clinical scenario 1
Bulk-forming agents like psyllium husk are considered safe in pregnancy due to lack of systemic absorption and can be used as adjunctive therapy 1